Zhui Chen
Founder bei ABBISKO CAYMAN LIMITED
Vermögen: 7 Mio $ am 31.03.2024
Profil
Zhui Chen is the founder of Abbisko Therapeutics Co., Ltd.
and Abbisko Cayman Ltd., both founded in 2016.
He is currently a Director at Abbisko Hong Kong Ltd.
since 2018 and a Member of the American Association for Cancer Research since 2007.
He was previously an Associate Director at Johnson & Johnson China Ltd.
from 2014 to 2016.
Dr. Chen received his doctorate degree from Duke University in 2003 and his undergraduate degree from The University of Texas at Austin in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED
2,63% | 02.04.2024 | 18 490 051 ( 2,63% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Zhui Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Founder | 12.04.2016 |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Founder | 12.04.2016 |
| Abbisko Hong Kong Ltd. | Director/Board Member | 01.03.2018 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01.01.2007 |
Ehemalige bekannte Positionen von Zhui Chen
| Unternehmen | Position | Ende |
|---|---|---|
Johnson & Johnson China Ltd.
 Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Part of Kenvue, Inc., Johnson & Johnson China Ltd. is a Chinese company that manufactures pharmaceutical products. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01.05.2016 |
Ausbildung von Zhui Chen
| Duke University | Doctorate Degree |
| The University of Texas at Austin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBISKO CAYMAN LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Johnson & Johnson China Ltd.
Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Part of Kenvue, Inc., Johnson & Johnson China Ltd. is a Chinese company that manufactures pharmaceutical products. The private company is based in Shanghai, China. | Health Technology |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Health Technology |
| Abbisko Hong Kong Ltd. |
